| bupropion sustained-release / Generic mfg. |
NCT00150241: A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation |
|
|
| Completed | 2 | 625 | US | CP-526,555 (varenicline) | Pfizer | Smoking Cessation | | 01/02 | | |
NCT00000457: Pharmacologic Relapse Prevention for Alcoholic Smokers |
|
|
| Completed | 2 | 195 | US | bupropion (Wellbutrin), bupropion, zyban, wellbutrin, Placebo | Mayo Clinic, National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcoholism, Smoking | 04/02 | 08/07 | | |
NCT00060814: Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients |
|
|
| Completed | 2 | 28 | US | Combined intervention | National Institute on Drug Abuse (NIDA) | Tobacco Use Disorder | 09/02 | 12/02 | | |
| Completed | 2 | 135 | US | Bupropion SR, Wellbutrin SR, Zyban SR, placebo, smoking cessation counseling | Watching Over Mothers & Babies Foundation, University of Arizona | Smoking Cessation, Pregnancy | 01/04 | 01/04 | | |
NCT00218231: Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia |
|
|
| Completed | 2 | 48 | US | 300 mg/day bupropion-sr, zyban, wellbutrin, 0 mg/day bupropion-sr, placebo | National Institute on Drug Abuse (NIDA) | Schizophrenia, Tobacco Use Disorder | 08/06 | 08/06 | | |
NCT00136760: Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia |
|
|
| Completed | 2 | 57 | US | Bupropion, zyban, wellbutrin, Contingent reinforcement plus placebo, non-contingent reinforcement plus bupropion, Non-contingent reinforcement plus placebo | Brown University, National Institute on Drug Abuse (NIDA) | Schizophrenia and Disorders With Psychotic Features, Tobacco Use Disorder | 03/09 | 03/09 | | |
NCT00330187: Combined Pharmaco/Behavior Therapy in Adolescent Smokers |
|
|
| Completed | 2 | 134 | US | Bupropion SR, Contingency Management, Placebo | Medical University of South Carolina, National Institute on Drug Abuse (NIDA) | Nicotine Dependence, Nicotine Use Disorder | 07/09 | 07/09 | | |
| Completed | 2 | 24 | US | Sugar Pill, Varenicline, Chantix, Bupropion HCl, Wellbutrin, Zyban | University of Minnesota, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) | Schizophrenia, Smoking Cessation | 08/12 | 08/12 | | |
NCT01286402: Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy |
|
|
| Completed | 2 | 11 | US | Bupropion SR, Zyban, Wellbutrin, Placebo | The University of Texas Health Science Center, Houston, M.D. Anderson Cancer Center, Gilstrap, Larry C, M.D., The Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houston | Smoking Cessation | 10/12 | 05/13 | | |
NCT00580853: The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior |
|
|
| Completed | 2 | 62 | US | varenicline, Chantix, bupropion, Zyban, Placebo | Yale University, National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Smoking Lapse Behavior | 10/16 | 10/16 | | |
NCT00593099: A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder |
|
|
| Completed | 1/2 | 5 | US | Bupropion, Zyban, Placebo | National Institute on Drug Abuse (NIDA) | Bipolar Disorder | 06/06 | 06/06 | | |
